These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 34486740)
21. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]. Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456 [TBL] [Abstract][Full Text] [Related]
23. Antidepressants in pregnancy: a systematic review. Udechuku A; Nguyen T; Hill R; Szego K Aust N Z J Psychiatry; 2010 Nov; 44(11):978-96. PubMed ID: 21034181 [TBL] [Abstract][Full Text] [Related]
24. Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. Şahingöz M; Yuksel G; Karsidag C; Uguz F; Sonmez EO; Annagur BB; Annagur A J Clin Psychopharmacol; 2014 Apr; 34(2):226-9. PubMed ID: 24525643 [TBL] [Abstract][Full Text] [Related]
26. Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Wisner KL; Sit DK; Hanusa BH; Moses-Kolko EL; Bogen DL; Hunker DF; Perel JM; Jones-Ivy S; Bodnar LM; Singer LT Am J Psychiatry; 2009 May; 166(5):557-66. PubMed ID: 19289451 [TBL] [Abstract][Full Text] [Related]
27. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Suri R; Altshuler L; Hellemann G; Burt VK; Aquino A; Mintz J Am J Psychiatry; 2007 Aug; 164(8):1206-13. PubMed ID: 17671283 [TBL] [Abstract][Full Text] [Related]
28. Maternal depression, antidepressant use in pregnancy and Apgar scores in infants. Jensen HM; Grøn R; Lidegaard Ø; Pedersen LH; Andersen PK; Kessing LV Br J Psychiatry; 2013 May; 202(5):347-51. PubMed ID: 23429204 [TBL] [Abstract][Full Text] [Related]
29. The impact of major depressive disorder and antidepressant medication before and during pregnancy on obstetric and neonatal outcomes: A nationwide population-based study. Wolgast E; Lilliecreutz C; Sydsjö G; Bladh M; Josefsson A Eur J Obstet Gynecol Reprod Biol; 2021 Feb; 257():42-50. PubMed ID: 33359923 [TBL] [Abstract][Full Text] [Related]
30. Do Maternal Pharmacogenetics Impact the Neonatal Abstinence Syndrome Following In Utero Exposure to Antidepressant Medications? Shea AK; Wang DY; Snelgrove JW; Dalfen A; Hewko S; Murphy KE J Obstet Gynaecol Can; 2021 Jun; 43(6):726-732. PubMed ID: 33303407 [TBL] [Abstract][Full Text] [Related]
31. The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Salisbury AL; O'Grady KE; Battle CL; Wisner KL; Anderson GM; Stroud LR; Miller-Loncar CL; Young ME; Lester BM Am J Psychiatry; 2016 Feb; 173(2):147-57. PubMed ID: 26514656 [TBL] [Abstract][Full Text] [Related]
32. Neonate characteristics after maternal use of antidepressants in late pregnancy. Källén B Arch Pediatr Adolesc Med; 2004 Apr; 158(4):312-6. PubMed ID: 15066868 [TBL] [Abstract][Full Text] [Related]
33. Short-term neonatal outcome among term infants after in utero exposure to serotonin reuptake inhibitors. Leibovitch L; Rymer-Haskel N; Schushan-Eisen I; Kuint J; Strauss T; Maayan-Metzger A Neonatology; 2013; 104(1):65-70. PubMed ID: 23711579 [TBL] [Abstract][Full Text] [Related]
34. Neonatal adaptation in infants prenatally exposed to antidepressants--clinical monitoring using Neonatal Abstinence Score. Forsberg L; Navér L; Gustafsson LL; Wide K PLoS One; 2014; 9(11):e111327. PubMed ID: 25365553 [TBL] [Abstract][Full Text] [Related]
35. Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates. Gurnot C; Martin-Subero I; Mah SM; Weikum W; Goodman SJ; Brain U; Werker JF; Kobor MS; Esteller M; Oberlander TF; Hensch TK Epigenetics; 2015; 10(5):361-72. PubMed ID: 25891251 [TBL] [Abstract][Full Text] [Related]
36. [Current evaluation of teratogenic and fetotoxic effects of psychotropic drugs]. Watanabe O Seishin Shinkeigaku Zasshi; 2014; 116(12):996-1004. PubMed ID: 25823351 [TBL] [Abstract][Full Text] [Related]
37. Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study. Oberlander TF; Warburton W; Misri S; Aghajanian J; Hertzman C Br J Psychiatry; 2008 May; 192(5):338-43. PubMed ID: 18450656 [TBL] [Abstract][Full Text] [Related]
38. Safety of newer antidepressants in pregnancy. Way CM Pharmacotherapy; 2007 Apr; 27(4):546-52. PubMed ID: 17381382 [TBL] [Abstract][Full Text] [Related]
39. Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. Brown AS; Gyllenberg D; Malm H; McKeague IW; Hinkka-Yli-Salomäki S; Artama M; Gissler M; Cheslack-Postava K; Weissman MM; Gingrich JA; Sourander A JAMA Psychiatry; 2016 Nov; 73(11):1163-1170. PubMed ID: 27732704 [TBL] [Abstract][Full Text] [Related]
40. Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis. Ross LE; Grigoriadis S; Mamisashvili L; Vonderporten EH; Roerecke M; Rehm J; Dennis CL; Koren G; Steiner M; Mousmanis P; Cheung A JAMA Psychiatry; 2013 Apr; 70(4):436-43. PubMed ID: 23446732 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]